VEGF Trap as a Novel Antiangiogenic Treatment Currently in Clinical Trials for Cancer and Eye Diseases, and VelociGene(R)- based Discovery of the Next Generation of Angiogenesis Targets-Reference-Cited by-同舟云学术

VEGF Trap as a Novel Antiangiogenic Treatment Currently in Clinical Trials for Cancer and Eye Diseases, and VelociGene(R)- based Discovery of the Next Generation of Angiogenesis Targets

Published:2005-01-01 Issue:0 Volume:70 Page:411-418
ISSN:0091-7451
Container-title:Cold Spring Harbor Symposia on Quantitative Biology
language:en
Short-container-title:Cold Spring Harbor Symposia on Quantitative Biology

Author:

RUDGE J.S.,THURSTON G.,DAVIS S.,PAPADOPOULOS N.,GALE N.,WIEGAND S.J.,YANCOPOULOS G.D.

Publisher

Cold Spring Harbor Laboratory

Subject

Genetics,Molecular Biology,Biochemistry

Reference84 articles.

1. Update on Clinical Trials Targeting Vascular Endothelial Growth Factor in Cancer

2. Brown D.M. etal IOVS 2006. 47: ARVO E-Abstract 2963.

3. Mechanisms of angiogenesis and arteriogenesis

4. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes of Double-dose Aflibercept Treatment for Refractory Wet Age-related Macular Degeneration;Journal of the Korean Ophthalmological Society;2024-08-15

2. Production of a biosimilar version of aflibercept to improve VEGF blocker cytotoxicity on endothelial cells;Growth Factors;2023-06-28

3. Comparison of intravitreal aflibercept and dexamethasone implant in the treatment of macular edema associated with diabetic retinopathy or retinal vein occlusion: a Meta-analysis and systematic review;International Journal of Ophthalmology;2022-09-18

4. Clinical Outcomes of Aflibercept Treatment for Treatment-naive Exudative Age-related Macular Degeneration;Journal of Retina;2021-11-30

5. The Novel Pathogenesis of Retinopathy Mediated by Multiple RTK Signals is Uncovered in Newly Developed Mouse Model;EBioMedicine;2018-05